Palo Alto, CA, United States of America

Colin J Mckinlay

This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Leland Stanford Junior University. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Colin J Mckinlay. Retrieved from https://idiyas.com/inventor/colin-j-mckinlay-8rtbxw7s

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Colin J. Mckinlay: Innovator in Nucleic Acid Delivery

Introduction

Colin J. Mckinlay is a notable inventor based in Palo Alto, California. He has made significant contributions to the field of nucleic acid delivery through his innovative research and patents. His work is particularly focused on developing cell-penetrating complexes that enhance the delivery of nucleic acids.

Latest Patents

Colin J. Mckinlay holds a patent for "Immolative Cell-Penetrating Complexes for Nucleic Acid Delivery." This patent represents a breakthrough in the methods used to deliver genetic material into cells, which has important implications for gene therapy and molecular biology.

Career Highlights

Colin is affiliated with Leland Stanford Junior University, where he conducts his research and collaborates with other leading scientists in the field. His work has garnered attention for its potential applications in medical and biotechnological advancements.

Collaborations

Colin has worked alongside esteemed colleagues such as Robert M. Waymouth and Paul Wender. These collaborations have further enriched his research and contributed to the development of innovative solutions in nucleic acid delivery.

Conclusion

Colin J. Mckinlay is a prominent figure in the realm of nucleic acid delivery, with a focus on creating effective cell-penetrating complexes. His contributions to the field are paving the way for future advancements in gene therapy and molecular biology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…